[Federal Register Volume 69, Number 137 (Monday, July 19, 2004)]
[Notices]
[Page 42989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-16269]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent to Grant Exclusive Patent License; American 
BioHealth Group, LLC

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to American BioHealth Group, LLC, a revocable, nonassignable, 
exclusive license to practice worldwide the Government-Owned inventions 
described in U.S. Patent No. 6,649,621, issued 18 November 2003 
entitled, ``Prevention or Reversal of Sensorineural Hearing Loss (SNHL) 
Through Biological Mechanisms'' in the field of prevention and 
treatment of noise-induced sensorineural inner ear damage by 
administering either a nutraceutical or a pharmaceutically effective 
amount of antioxidant compounds through various methods to include, but 
not limited to, tablets, capsules, topical delivery vehicles and 
sterile IV administered products.

DATES: Anyone wishing to object to the granting of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any.

ADDRESSES: Submit written objections to the Office of Technology 
Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver 
Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428 or e-mail 
at: [email protected].

    Dated: July 8, 2004.
J. H. Wagshul,
Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register 
Liaison Officer.
[FR Doc. 04-16269 Filed 7-16-04; 8:45 am]
BILLING CODE 3810-FF-P